A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
7/2/2026
BreakingGlaucomaPharmaRegulationSurgical
MACs Propose Limiting Coverage for iDose TR
Five Medicare administrative contractors (MACs) in the US are proposing to limit coverage for procedures implanting the Glaukos iDose TR in patients with glaucoma. The iDose TR is a drug-eluting in...
7/2/2026
BreakingRegulationThyroid Eye Disease
Viridian Announces US FDA Approval and Launch of Lumvoa for Thyroid Eye Disease
Viridian Therapeutics announced June 29 that the US FDA had approved Lumvoa (veligrotug-vvze), an infusion treatment for thyroid eye disease (TED). The Waltham, Massachusetts, company said it would...
7/2/2026
BreakingDealsPresbyopia
Lenz Licenses Vizz Presbyopia Drops to Arrotex for Australia, New Zealand
Lenz Therapeutics announced June 24 that it had granted Arrotex Pharmaceuticals exclusive rights to develop Vizz (aceclidine ophthalmic solution) 1.44% eye drops for presbyopia in Australia and New...
7/2/2026
BreakingDealsIndustryRetina
LambdaVision Collaborates with Vast, Creator of Planned Commercial Space Station
LambdaVision reported June 24 that it had signed a memorandum of understanding with Vast related to future research and manufacturing activities for LambdaVision’s artificial retina aboard Vast’s p...
7/2/2026
BreakingPharmaRegulation
Supreme Court Ruling in Favor of Bayer May Shut Down Thousands of Roundup Lawsuits
German company Bayer won a landmark ruling in the US Supreme Court on June 25, when justices ruled 7-2 that federal pesticide laws preempt “failure-to-warn” claims made under state law. The plainti...
7/2/2026
BreakingDiagnosticFundus
Optos Celebrates Milestone of 30 Thousand Installed Imaging Devices
UK-based Optos reported June 25 that it had reached the milestone of 30 thousand imaging devices installed globally. The company developed and continues to be a leader in single-capture, 200-degree...
7/2/2026
BreakingCataractDiagnosticGlaucomaMicroscopesRetinaSurgical
BVI Opens Experience Hub for Ophthalmic Training, Collaboration
BVI Medical, of Waltham, Massachusetts, announced June 15 that it had opened a new BVI Experience Hub within its offices in Sant Cugat, Spain. The hub is designed to support ophthalmic training and...
7/2/2026
BreakingLow Vision
Braille Institute Names Six Recipients of Community Hero Awards
The Braille Institute of America honored six recipients of its Community Hero Awards at a dinner on June 25. The awards recognize extraordinary organizations and leaders for breaking barriers, expa...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.